Skip to main content
Log in

Localization of the bronchodilator effect induced by type A natriuretic peptide in asthmatic subjects

  • Original Article
  • Published:
The clinical investigator Aims and scope Submit manuscript

Abstract

Type A natriuretic peptide (CDD/ANP99-126) in its circulating form was analyzed with respect to the localization of its bronchodilating effects in asthmatic subjects in vivo. The intravenous infusion of 5.7, 11.4, and 17.1 pmol kg−1 min CDD/ANP-99-126 caused a significant bronchodilation of both central and peripheral airways. While the localization of the bronchodilating effects was similar to β2-agonists, an improvement in lung function parameters comparable to these substances was not observed. But other members of the natriuretic peptide family may reveal a stronger bronchodilating potency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

FEV:

forced expiratory volume in 1 s

FVC:

forced vital capacity

PEF:

peak expiratory flow

MEF75, MEF50, MEF25 :

maximal expiratory flow at 75%, 50%, 25% of forced vital capacity

References

  1. Banerjee MR, Newman JH (1990) Acute effects of atrial natriuretic peptide on lung mechanics and hemodynamics in awake sheep. J Appl Physiol 69:728–733

    Google Scholar 

  2. Chanez P, Mann C, Bousquet J, Chabrier PE, Godard P, Braquet P, Michel FB (1990) Atrial natriuretic factor (ANF) is a potent bronchodilator in asthma. J Allergy Clin Immunol 86:321–324

    Google Scholar 

  3. Forssmann K, Hock D, Herbst F, Schulz-Knappe P, Talartschik J, Scheler F, Forssmann WG (1986) Isolation and structural analysis of circulating human cardiodilatin (alpha ANP). Klin Wochenschr 64:1276–1280

    Google Scholar 

  4. Hamel R, Ford-Hutchinson AW (1986) Relaxant profile of synthetic atrial natriuretic factor on guinea pig pulmonary tissues. Eur J Pharmacol 121:151–155

    Google Scholar 

  5. Hulks G, Jardine A, Connell JMC, Thomson NC (1989) Bronchodilator effect of atrial natriuretic peptide in asthma. Br Med J 299:1081–1082

    Google Scholar 

  6. Kangawa K, Matsuo H (1984) Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun 118:131–139

    Google Scholar 

  7. Miller WIT, Scacci R, Gast LR (1987) Laboratory evaluation of pulmonary function. Lippincott, Philadelphia

    Google Scholar 

  8. Quanjer PH (1983) Standardized lung function testing. Bull Eur Physiopathol Respir 19 [Suppl 5]:1–95

    CAS  PubMed  Google Scholar 

  9. Rosenzweig A, Seidman CE (1991) Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem 60:229–255

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: T. Edge

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flüge, T., Fabel, H., Wagner, T.O.F. et al. Localization of the bronchodilator effect induced by type A natriuretic peptide in asthmatic subjects. Clin Investig 72, 772–774 (1994). https://doi.org/10.1007/BF00180545

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00180545

Key words

Navigation